Jon Haskins

Jon Haskins, Ph.D. has a diverse work experience spanning various roles and companies. Jon is currently working at Mersana Therapeutics as the Executive Director of Product Strategy & Program Leadership since October 2023. Prior to that, they held the position of Senior Director of New Product Strategy at Mersana Therapeutics from February 2022 to October 2023.

Before joining Mersana Therapeutics, Jon worked at GSK as the Director of R&D Strategy Development and Portfolio Governance from April 2020 to February 2022. Jon also served as the Associate Director of Zejula HCP Marketing from July 2019 to April 2020.

Jon has also gained extensive experience at TESARO, Inc., where they held multiple roles including Associate Director of Global New Product Strategy and Business Operations from January 2019 to June 2019, Senior Manager of Global New Product Strategy from March 2018 to January 2019, and Manager of Global New Product Strategy from June 2017 to March 2018.

Earlier in their career, Jon worked as a Consultant at ClearView Healthcare Partners from August 2015 to May 2017. Jon also served as a Scientific Consultant at IsoPlexis from April 2013 to September 2014.

Jon started their career as an Intern at Bristol-Myers Squibb where they worked on lead profiling on a drug screening project from June to August 2010. Before that, they conducted independent research as an undergraduate at Fairfield University from 2008 to 2010, supported by various scholarships.

Overall, Jon Haskins, Ph.D. brings a broad range of expertise in strategic product development, program leadership, marketing, consulting, and scientific research to their current role at Mersana Therapeutics.

Jon Haskins, Ph.D. obtained their Bachelor of Science degree in Biology, General from Fairfield University, where they attended from 2006 to 2010. Jon then pursued their Doctor of Philosophy (PhD) in Experimental Pathology - Molecular Medicine at Yale University from 2010 to 2015.